Doug Brown

Doug Brown has more than 25 years of healthcare deal experience and joined Raymond James from NeoGenomics Laboratories, where he served as chief strategy and corporate development officer. He previously held senior investment banking positions at SVB Leerink, Lazard and Wachovia Securities. In addition to his role as healthcare investment banking group head, Mr. Brown leverages his prior experience and knowledge to expand the Raymond James life sciences coverage, inclusive of diagnostics, life science tools and informatics. Mr. Brown holds a Bachelor of Business Administration degree from the University of Texas and an MBA from Duke University’s Fuqua School of Business.